Tufton Capital Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,250
| Closed | -$219K | – | 127 |
|
|
2021
Q1 | $219K | Sell |
1,250
-300
| -19% | -$52.6K | 0.04% | 120 |
|
|
2020
Q4 | $263K | Hold |
1,550
| – | – | 0.05% | 110 |
|
|
2020
Q3 | $251K | Hold |
1,550
| – | – | 0.05% | 109 |
|
|
2020
Q2 | $252K | Sell |
1,550
-100
| -6% | -$16.3K | 0.06% | 105 |
|
|
2020
Q1 | $211K | Hold |
1,650
| – | – | 0.05% | 105 |
|
|
2019
Q4 | $230K | Buy |
+1,650
| New | +$230K | 0.05% | 111 |
|
|
2019
Q3 | – | Sell |
-1,650
| Closed | -$212K | – | 119 |
|
|
2019
Q2 | $212K | Hold |
1,650
| – | – | 0.04% | 120 |
|
|
2019
Q1 | $212K | Buy |
+1,650
| New | +$212K | 0.05% | 116 |
|
|
2018
Q4 | – | Sell |
-1,850
| Closed | -$251K | – | 119 |
|
|
2018
Q3 | $251K | Hold |
1,850
| – | – | 0.05% | 113 |
|
|
2018
Q2 | $221K | Sell |
1,850
-800
| -30% | -$95.6K | 0.05% | 115 |
|
|
2018
Q1 | $318K | Hold |
2,650
| – | – | 0.06% | 103 |
|
|
2017
Q4 | $330K | Hold |
2,650
| – | – | 0.06% | 106 |
|
|
2017
Q3 | $355K | Hold |
2,650
| – | – | 0.07% | 102 |
|
|
2017
Q2 | $333K | Hold |
2,650
| – | – | 0.07% | 96 |
|
|
2017
Q1 | $315K | Buy |
+2,650
| New | +$315K | 0.06% | 98 |
|